Status:
UNKNOWN
Bronchiactasis as Atypical Presentation in COVID-19
Lead Sponsor:
Assiut University
Conditions:
Covid19 in Bronchiactasis
Eligibility:
All Genders
18-75 years
Brief Summary
To evaluate the prevelance and pattern of bronchiectasis as atypical COVID-19 presentation
Detailed Description
bronchiectasis is achronic inflammatory lung disease. It is defined by the presence of permanent and abnormal dilatation of the bronchi. which leads to chronic sputum production and impaired bacterial...
Eligibility Criteria
Inclusion
- Significant sputum production (≥ 10 ml per day)
- Adult patients aged 18 years or older of both sex and diagnosed as COVID-19 positive by PCR either during same visit or in previous visits during the 2020-2021 who have CT scan examination of the chest during acute diseases or at follow up
Exclusion
- Children under 18 years old, patients with known chronic chest diseases, and patients who are not examined by CT scan of the chest
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04910113
Start Date
June 1 2021
End Date
January 1 2022
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maha Ahmed Okasha
Asyut, Egypt